DelveInsight’s, “Metastatic Colorectal Cancer Pipeline Insight” report provides comprehensive insights about 80+ companies ...

Pharmaceutical ads are difficult to avoid in American television programming and a growing number of them promote a class of ...

Antibody drugs have reshaped how we treat diseases. By harnessing the immune system to destroy tumours or temper excessive inflammation in autoimmune disorders, these therapeutics have become ...

Kinases are enzymes that catalyze the addition of a phosphate group (PO43−) to substrates, usually proteins. The phosphate generally comes from adenosine triphosphate (ATP). Kinases and ...

The international consulting firm Clarivate makes its bet among the novelties ready for the medicine cabinet this year: three ...

Dr. Weickert will present Pacylex at the OBIO® Investment Summit and Early Technology Showcase February 5-7, 2025, at the Arcadian Court & Loft, Toronto Mr. Kamdar will present Pacylex at the PWMC ...

Inhibikase Therapeutics announced disappointing results from a Phase 2 trial for its Parkinson’s disease drug, risvodetinib, ...

Inhibikase Therapeutics, Inc. (IKT), a biopharmaceutical company with a market capitalization of $189.48 million, has announced the halting of further development of its Parkinson's disease drug, ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

Google TV is one of the best streaming platforms out there, running on everything from smart TVs to the best streaming devices, and Google TV Streamer. This web-connected OS is built to make ...

They’re also called serotonin receptor agonists. Serotonin is a neurotransmitter that nerve cells produce. It’s found in different nerves all over the body, including the brain. While the ...

CD19-directed chimeric antigen receptor (CAR) T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for patients with autoimmune diseases.